AngioDynamics Inc.
ANGO | NASDAQ
$15.42
-$0.02 (-0.13%)
At close: Sep 21, 2026, 4:00 PM ET
$15.48
+$0.06 (+0.39%)
Pre-market:
Sep 22, 2026, 7:54 AM ET
Fiscal Year Period Ending | FY 2026 May 30, 2026 | FY 2025 May 30, 2025 | FY 2024 May 30, 2024 | FY 2023 May 30, 2023 | FY 2022 May 30, 2022 | FY 2021 May 30, 2021 |
|---|---|---|---|---|---|---|
Revenue | 320.17M | 292.5M | 303.91M | 338.75M | 316.22M | 291.01M |
Cost of Revenue | 145.28M | 134.79M | 149.22M | 164.51M | 150.49M | 134.22M |
Gross Profit | 174.89M | 157.71M | 154.7M | 174.25M | 165.73M | 156.79M |
Operating Income | -39.93M | -39.95M | -192.44M | -51.18M | -28.47M | -35.28M |
Interest Income | n/a | 978K | 1.61M | n/a | n/a | n/a |
Pretax Income | -36.3M | -34.03M | -191.64M | -54.44M | -29.95M | -36.05M |
Net Income | -36.74M | -33.99M | -184.35M | -52.44M | -26.55M | -31.55M |
Selling & General & Admin | 157.09M | 145.23M | 143.98M | 144.25M | 133.75M | 117.22M |
Research & Development | 29.45M | 26.22M | 31.51M | 29.88M | 30.74M | 36.39M |
Other Expenses | 28.28M | 26.21M | 171.64M | 51.29M | 29.71M | 38.46M |
Operating Expenses | 214.82M | 197.66M | 347.13M | 225.43M | 194.2M | 192.07M |
Interest Expense | 299K | n/a | n/a | 2.7M | 688K | 861K |
Selling & Marketing Expenses | 113.4M | 103.14M | 102.82M | 104.25M | 95.3M | 81.31M |
Cost & Expenses | 360.1M | 332.45M | 496.35M | 389.93M | 344.69M | 326.29M |
Income Tax Expense | 442K | -39K | -7.29M | -2M | -3.4M | -4.5M |
Shares Outstanding (Basic) | 41.53M | 40.98M | 40.18M | 39.48M | 39.01M | 38.34M |
Shares Outstanding (Diluted) | 41.53M | 40.98M | 40.18M | 39.48M | 39.01M | 38.34M |
EPS (Basic) | -0.88 | -0.83 | -4.59 | -1.33 | -0.68 | -0.82 |
EPS (Diluted) | -0.88 | -0.83 | -4.59 | -1.33 | -0.68 | -0.82 |
EBITDA | -36M | 1.74M | -6.13M | 12.19M | 11.13M | -9.28M |
EBIT | -36M | -24.06M | -33.84M | -18.68M | -18.22M | -35.19M |
Depreciation & Amortization | n/a | 25.8M | 27.71M | 30.87M | 29.35M | 25.92M |
Add to Watchlist
Select watchlists to add or remove ANGO